Victory Capital Management
VYGR icon

Victory Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Victory Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,892
Closed -$40.1K – 2559
2025
Q2 		$40.1K Hold
12,892
– – ﹤0.01% 2398
2025
Q1 		$43.6K Hold
12,892
– – ﹤0.01% 2376
2024
Q4 		$73.1K Hold
12,892
– – ﹤0.01% 2358
2024
Q3 		$75.4K Hold
12,892
– – ﹤0.01% 2353
2024
Q2 		$102K Buy
12,892
+1,630
+14% +$13.7K ﹤0.01% 2294
2024
Q1 		$105K Buy
+11,262
New +$95.1K ﹤0.01% 2297
2020
Q2 		– Sell
-7,578
Closed -$70K – 3286
2020
Q1 		$70K Buy
7,578
+1,379
+22% +$15.8K ﹤0.01% 2648
2019
Q4 		$86K Buy
6,199
+1,954
+46% +$28.4K ﹤0.01% 2575
2019
Q3 		$73K Buy
+4,245
New +$89.1K ﹤0.01% 2546
2018
Q4 		– Sell
-73,630
Closed -$1.39M – 1816
2018
Q3 		$1.39M Sell
73,630
-3,940
-5% -$75.6K ﹤0.01% 1195
2018
Q2 		$1.52M Sell
77,570
-4,320
-5% -$85.4K ﹤0.01% 1140
2018
Q1 		$1.54M Buy
81,890
+8,970
+12% +$194K ﹤0.01% 1141
2017
Q4 		$1.21M Buy
+72,920
New +$1.25M ﹤0.01% 1182

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Victory Capital Management's VYGR Position: Q3 2025 in Review

Victory Capital Management sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 12,892 shares — an estimated $40.1K sold.

Victory Capital Management first reported a position in VYGR in Q4 2017 and held it in 13 quarters. The position peaked at $1.54M in Q1 2018. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Victory Capital Management reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Victory Capital Management sold 12,892 Voyager Therapeutics shares in Q3 2025, an estimated $40.1K.
  • Victory Capital Management first reported a position in Voyager Therapeutics in Q4 2017 and held it in 13 quarters.
  • Victory Capital Management's Voyager Therapeutics position peaked at $1.54M in Q1 2018.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.